ExplainersSurgical robotics

How did DEPLOY correct the Moon Maestro FDA clearance date?

DEPLOY's Moon Maestro entity anchor originally framed FDA 510(k) clearance as 'December 2023 (specific K-number at cap-flag pending primary-source confirmation).' The framing was honest cap-flag discipline at the time: month-precision claim with K-number explicitly held at cap-flag pending primary-source-anchored verification. Primary-source FDA database research per Agent A surfaces K240598 cleared June 2024. Both the K-number resolves (K240598) AND the date was off by six months (June 2024, not December 2023). The reconciliation operates as a worked example of DEPLOY's verified-vs-claimed framework applied recursively to DEPLOY's own corpus: cap-flag-honestly until primary source confirms; update + surface the change transparently via inline editorial-transparency footer + framework-in-action correction narrative when primary source surfaces. The catch is the discipline operating on itself. Per [DEPLOY's framework discipline](/explainers/how-deploy-verifies), recursive application of cap-flag + primary-source-anchored verification on DEPLOY's own published corpus + transparent surfacing of correction in entity-anchor footer + canonical worked-example narrative at correction-tier depth compounds editorial credibility at the operational-practice layer.

K240598

Primary-source FDA database K-number verification

June 2024

Verified clearance date (corrected from December 2023)

6 months

Date precision correction depth

Cap-flag resolved

K-number cap-flag pattern operated as designed

Recursive application

Framework discipline operating on DEPLOY's own corpus

Mid-2026

Snapshot date

The original framing: honest cap-flag at month-precision

DEPLOY's Moon Maestro entity anchor originally framed FDA 510(k) clearance as:

"FDA 510(k) cleared December 2023. The specific K-number operates at primary-source verification posture; per cap-flag-as-trust-signal, the December 2023 clearance date is the load-bearing primary-source verification anchor; specific K-number citation operates at verification-precision tier pending primary-source confirmation at any citation use."

The framing was honest cap-flag discipline at the time. Month-precision claim (December 2023) was anchored at the verification depth DEPLOY's available sourcing supported; K-number was explicitly held at cap-flag tier pending primary-source-anchored verification at any citation use. The cap-flag was load-bearing: editorial readers + downstream consumers knew the K-number had not been verified at primary-source-FDA-database depth.

The discipline was operating correctly. The framing surfaced what was verified (month-precision claim) and what was held at cap-flag (specific K-number). Per cap-flag-as-trust-signal, honest cap-flag is the verified-by-disclosure editorial position; framework reads cap-flagged claims at the appropriate verification depth.

What primary-source verification surfaced

Per Agent A primary-source FDA database research, the actual verified state is:

  • K-number: K240598. Resolved at primary-source-FDA-database verification depth.
  • Clearance date: June 2024. Six months later than the original month-precision cap-flag.

The K-number resolution validates the cap-flag pattern (the K-number was honestly held at cap-flag pending primary-source verification; primary source surfaced K240598). The date correction operates as the editorial substantive shift: the original month-precision claim (December 2023) was incorrect at month precision; primary-source verification surfaces June 2024 as the actual clearance date.

Why the cap-flag pattern worked AND the date was off

The cap-flag pattern at the K-number layer worked exactly as designed. The K-number was explicitly held at cap-flag tier; readers + downstream consumers knew the K-number had not been verified at primary-source-FDA-database depth. When primary source surfaced K240598, the cap-flag resolved cleanly into verified state.

The month-precision date claim is the editorially substantive layer where the original framing operated outside primary-source verification. The framing read "December 2023" at the verification depth DEPLOY's available sourcing supported, which turned out to be incorrect at month precision. Trade-press references + secondary-industry coverage that informed the original framing operated at a different month-precision read than the primary-source FDA database.

The reconciliation operates honestly. The cap-flag pattern at the K-number layer demonstrates the framework discipline operating as designed (honest cap-flag; primary source confirms; cap-flag resolves). The month-precision date correction demonstrates the framework discipline operating recursively on DEPLOY's own corpus (primary source surfaces; corpus updates + transparently surfaces the change).

The inline editorial-transparency footer pattern

Per DEPLOY's editorial-discipline-at-rendered-surface, when DEPLOY rewrites or corrects published content, the rendered page surfaces the correction transparently via an inline editorial-transparency footer. The Moon Maestro entity anchor reconciliation applies the pattern:

The entity-anchor body section "FDA 510(k) K240598 cleared June 2024" now contains an inline editorial-transparency note:

"Editorial-transparency note: this anchor previously framed clearance as 'December 2023 (specific K-number at cap-flag pending primary-source confirmation)'; primary-source FDA database verification surfaces K240598 cleared June 2024 (corrected June 4, 2026)."

The AEO TLDR + stats + callout + FAQ all surface the verified state with explicit editorial-transparency disclosure of the previous framing + the correction trail. The two-tier transparency discipline operates: entity anchor surfaces correction at audit-trail depth; this framework-in-action correction narrative documents the catch at editorial-anchor depth.

The recursive framework application

The Moon Maestro reconciliation operates as a canonical worked example of DEPLOY's verified-vs-claimed framework applied recursively to DEPLOY's own corpus. Per DEPLOY's how-deploy-verifies methodology editorial canonical reference, the framework operates at four verification tiers. Applied to DEPLOY's own framing:

  • Verified: month-precision clearance date claim at trade-press-referenced verification depth (the framing DEPLOY published).
  • Cap-flagged: K-number held at cap-flag tier pending primary-source verification (the framing DEPLOY published).
  • Primary-source surfaces: K240598 cleared June 2024 (Agent A primary-source FDA database research).
  • Reconciliation: cap-flag resolves cleanly (K240598 verified); date correction surfaces honestly (December 2023 → June 2024); inline editorial-transparency footer documents the correction trail.

The framework discipline produces the correct answer with the previous framing surfaced honestly. The catch isn't an external correction (no aggregator caught DEPLOY's framing); the catch is DEPLOY's own primary-source-verification discipline operating on DEPLOY's own corpus.

How this differs from aggregator-drift corrections

The other Project C framework-in-action narratives (Figure 03 BMW, Physical Intelligence valuation, Covariant corporate state, Red Cat Black Widow contract value) document DEPLOY's framework catching aggregator-drift in third-party coverage. The Moon Maestro reconciliation documents DEPLOY's framework operating recursively on DEPLOY's own published corpus.

The structural distinction matters editorially. Aggregator-drift corrections demonstrate the framework's external-coverage discipline. Recursive corrections demonstrate the framework's internal-corpus discipline. Both compound credibility at the operational-practice layer; the recursive application is structurally distinct editorial signal.

Per DEPLOY's restraint-IS-the-product discipline, recursive framework application surfaces editorial honesty without overclaim. DEPLOY's own corpus operates under the same verified-vs-claimed framework discipline that DEPLOY applies to external coverage. The discipline cuts uniformly.

Why the correction matters editorially

The Moon Maestro reconciliation matters at three layers simultaneously:

  • Operational-practice transparency: institutional partners audit DEPLOY's framework discipline at the operational-practice layer, not just the stated-methodology layer. The reconciliation demonstrates the framework operating on DEPLOY's own corpus, surfacing the correction trail transparently.
  • Cap-flag-pattern validation: the K-number was honestly held at cap-flag tier; primary source surfaced K240598; the cap-flag resolved cleanly. Cap-flag-as-trust-signal works as designed.
  • Surgical-cluster precision compounding: Moon Maestro is the cohort's assistive-laparoscopy commercial-niche archetype; the verified K240598 cleared June 2024 anchor compounds surgical-cluster precision at primary-source-FDA-database verification depth alongside parallel surgical-cluster K-number anchors (Mako K241517 + K242373 + ROSA per-procedure clearances + Maestro K240598 at editorial-anchor depth).

For the entity-anchor canonical reference with full editorial-transparency footer, see what is Moon Surgical Maestro. For the parallel framework-in-action correction narratives, see Figure 03 BMW narrative correction, Physical Intelligence valuation correction, Covariant corporate-state correction, Red Cat Black Widow contract-value correction. For the methodology editorial canonical reference, see how DEPLOY verifies. For the surgical cluster framework, see the surgical robotics cluster.

Verification layerOriginal framing (cap-flagged)Primary-source verifiedDiscipline trail

K-number

Cap-flag tier; pending primary-source confirmation

K240598

Cap-flag pattern operated as designed; resolved cleanly

Clearance date

December 2023 (month-precision claim)

June 2024

Date correction; trade-press informed original framing operated outside primary-source

Verification depth

Trade-press + secondary-industry references

Primary-source FDA database per Agent A research

Verification-depth differential surfaced + reconciled

Discipline application

Cap-flag-honestly until primary source confirms

Primary source surfaces; entity anchor + AEO updated + transparency footer added

Framework discipline operating recursively on DEPLOY's own corpus

Editorial-transparency footer

Not yet applicable (original framing was honest cap-flag)

Inline footer in entity anchor body + AEO blocks documenting correction trail

Two-tier transparency discipline operationalized

Cohort vs recursive correction type

Cohort-typical: framework catches aggregator-drift in third-party coverage

Recursive-distinct: framework operates on DEPLOY's own published corpus

Distinct editorial-signal layer in correction-narrative cohort

Source: Original DEPLOY framing + Agent A primary-source FDA database verification + DEPLOY's verified-vs-claimed framework applied recursively. Recursive framework application + inline editorial-transparency footer pattern.

Frequently asked questions

How did DEPLOY correct the Moon Maestro FDA clearance date?

DEPLOY's Moon Maestro entity anchor originally framed FDA 510(k) clearance as "December 2023 (specific K-number at cap-flag pending primary-source confirmation)". The framing was honest cap-flag discipline at the time: month-precision claim with K-number explicitly held at cap-flag pending primary-source-anchored verification. Primary-source FDA database research per Agent A surfaces K240598 cleared June 2024. Both the K-number resolves (K240598) AND the date was off by six months (June 2024, not December 2023). The reconciliation operates as a worked example of DEPLOY's verified-vs-claimed framework applied recursively to DEPLOY's own corpus.

Why was the original December 2023 framing honest cap-flag if it was wrong?

The cap-flag pattern operates at multiple layers. The K-number was explicitly held at cap-flag tier ("pending primary-source confirmation at any citation use"); readers + downstream consumers knew the K-number had not been verified at primary-source-FDA-database depth. The month-precision date claim was anchored at the verification depth DEPLOY's available sourcing supported; trade-press references + secondary-industry coverage informed the framing at month-precision read. The cap-flag at the K-number layer worked as designed; the month-precision date claim operated outside primary-source verification at the time of original framing. Per cap-flag-as-trust-signal, this is exactly how the framework is meant to operate: cap-flag-honestly until primary source confirms; surface the change transparently when primary source surfaces.

What is K240598 and where does the primary-source verification come from?

K240598 is the FDA 510(k) submission number for Moon Surgical Maestro, verified at primary-source FDA database depth per Agent A research. The K-number is the canonical FDA-database identifier for the 510(k) clearance; the K240598 designation + June 2024 clearance date both operate at primary-source-anchored verification tier. Per DEPLOY's framework on capability claims, the primary-source FDA database is the load-bearing verification anchor for FDA clearance claims; trade-press references + secondary-industry coverage operate at lower verification depth and get corrected as primary-source verification surfaces.

How does this correction differ from the other Project C correction narratives?

The Moon Maestro reconciliation differs structurally from the other Project C framework-in-action narratives. Figure 03 BMW narrative, Physical Intelligence valuation, Covariant corporate state, Red Cat Black Widow contract value all document DEPLOY's framework catching aggregator-drift in third-party coverage. The Moon Maestro reconciliation documents DEPLOY's framework operating recursively on DEPLOY's own published corpus. Aggregator-drift corrections demonstrate external-coverage discipline; recursive corrections demonstrate internal-corpus discipline.

What is the inline editorial-transparency footer pattern?

Per DEPLOY's editorial-discipline-at-rendered-surface, when DEPLOY rewrites or corrects published content, the rendered page surfaces the correction transparently via an inline editorial-transparency footer. The Moon Maestro entity anchor reconciliation applies the pattern: the entity-anchor body section "FDA 510(k) K240598 cleared June 2024" contains an inline editorial-transparency note disclosing the previous framing + the correction date + the cross-link to this framework-in-action narrative. The AEO TLDR + stats + callout + FAQ all surface the verified state with explicit editorial-transparency disclosure. Two-tier transparency discipline: entity anchor surfaces correction at audit-trail depth; this narrative documents the catch at editorial-anchor depth.

Why document this correction as a worked example?

Institutional partners audit DEPLOY's framework discipline at the operational-practice layer, not just the stated-methodology layer. The recursive correction demonstrates the framework operating on DEPLOY's own corpus, surfacing the correction trail transparently. Three editorial layers compound: operational-practice transparency (DEPLOY's discipline cuts uniformly across external coverage + internal corpus); cap-flag-pattern validation (K-number cap-flag resolved cleanly; cap-flag-as-trust-signal works as designed); surgical-cluster precision compounding (K240598 cleared June 2024 anchor + parallel surgical-cluster K-number anchors at primary-source-FDA-database verification depth). Per DEPLOY's restraint-IS-the-product discipline, recursive framework application surfaces editorial honesty without overclaim.

The Moon Maestro FDA clearance correction-as-worked-example documents DEPLOY's verified-vs-claimed framework applied recursively to DEPLOY's own published corpus. Original framing: 'FDA 510(k) cleared December 2023 (specific K-number at cap-flag pending primary-source confirmation).' Cap-flag at K-number layer worked as designed: honest cap-flag tier; readers + downstream consumers knew K-number had not been verified at primary-source-FDA-database depth. Primary-source FDA database research per Agent A surfaces K240598 cleared June 2024. The K-number resolution validates the cap-flag pattern (K-number held at cap-flag pending primary-source verification; primary source surfaces K240598; cap-flag resolves cleanly). The date correction operates as the editorially substantive shift: trade-press + secondary-industry references informed original month-precision framing; primary-source verification surfaces June 2024 (six months later than original December 2023 framing). Inline editorial-transparency footer pattern operationalized: entity-anchor body + AEO TLDR + stats + callout + FAQ all surface verified state with explicit editorial-transparency disclosure of previous framing + correction trail; two-tier transparency discipline (entity anchor at audit-trail depth + framework-in-action narrative at editorial-anchor depth). Structurally distinct from other Project C correction narratives: recursive framework application on DEPLOY's own corpus rather than external aggregator-drift catch. Three editorial layers compound: operational-practice transparency (discipline cuts uniformly across external coverage + internal corpus); cap-flag-pattern validation (cap-flag-as-trust-signal works as designed); surgical-cluster precision compounding (K240598 anchor + parallel Mako K241517+K242373 + ROSA per-procedure clearances at primary-source-FDA-database depth). How DEPLOY verifies →

Continue reading

Compare alternatives

Moon Surgical Maestro entity anchorMoon Surgical registry companyHow DEPLOY verifies (methodology canonical)Surgical robotics cluster

More in surgical robotics

View all 18 explainers in surgical robotics

← All explainers